The Swiss Medical Board has ceased its activities.

The website remains available but is no longer updated after June 30, 2022.

DE | EN | FR

Completed reports

Significant advances have been made in the treatment of prostate cancer in recent years, significantly improving the prognosis of patients with severe...

Read more

In this report, the Swiss Medical Board (SMB) compares the robot-assisted technique with conventional techniques for radical prostatectomy and...

Read more

The measurement of prostate-specific antigens (PSA test) is usually carried out with a view to the early diagnosis of prostate cancer, the most common...

Read more